Mangoceuticals, Inc. Common Stock (MGRX) Stock Price

MGRXStock

$0.39−77.86%52W

Market Cap$8.36M

P/E—

PEG Ratio—

Div yield—

Beta2.21

MGRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-4.83%

Price vs S&P 500 (4W)-34.15%

VGM Score19.20

Book Value / Share (Quarterly)$0.79

P/TBV (Annual)11.76x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)270.86%

Cash Flow / Share (Quarterly)$-0.29

Price vs S&P 500 (YTD)-60.19%

Gross Margin (TTM)52.42%

Net Profit Margin (TTM)-4632.82%

EPS (TTM)$-1.61

10-Day Avg Trading Volume5.84M

EPS Excl Extra (TTM)$-1.61

EPS (Annual)$-2.05

ROI (Annual)-135.80%

Gross Margin (Annual)54.91%

Cash / Share (Quarterly)$0.01

Revenue Growth QoQ (YoY)-37.92%

ROA (Last FY)-128.30%

Revenue Growth TTM (YoY)-18.88%

EBITD / Share (TTM)$-1.36

Operating Margin (TTM)-4604.64%

Cash Flow / Share (Annual)$-0.37

P/B Ratio0.68x

P/B Ratio (Quarterly)0.45x

EV / Revenue (TTM)21.66x

Net Interest Coverage (TTM)-198.43x

ROA (TTM)-113.12%

EPS Incl Extra (Annual)$-2.05

Current Ratio (Annual)1.74x

Quick Ratio (Quarterly)0.29x

3-Month Avg Trading Volume9.74M

52-Week Price Return-77.86%

Tangible BV / Share (Quarterly)$0.06

P/S Ratio (Annual)20.07x

Asset Turnover (Annual)0.03x

52-Week High$2.75

EPS Excl Extra (Annual)$-2.05

26-Week Price Return6.42%

Quick Ratio (Annual)1.73x

13-Week Price Return-12.53%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.29x

Enterprise Value$8.98M

Asset Turnover (TTM)0.02x

Pretax Margin (Annual)-4526.88%

Cash / Share (Annual)$0.09

3-Month Return Std Dev240.41%

ROE (Last FY)-135.80%

Net Interest Coverage (Annual)-133.83x

EPS Basic Excl Extra (Annual)$-2.05

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.61

ROI (TTM)-119.39%

P/S Ratio (TTM)22.08x

Revenue / Share (Annual)$0.05

Tangible BV / Share (Annual)$0.06

Price vs S&P 500 (52W)-96.17%

Year-to-Date Return-48.23%

5-Day Price Return-18.49%

EPS Normalized (Annual)$-2.05

ROA (5Y Avg)-267.86%

Net Profit Margin (Annual)-4526.77%

Month-to-Date Return-31.23%

Cash Flow / Share (TTM)$-0.48

EBITD / Share (Annual)$-1.93

Operating Margin (Annual)-4504.18%

EPS Basic Excl Extra (TTM)$-1.61

P/TBV (Quarterly)11.76x

P/B Ratio (Annual)0.75x

Inventory Turnover (TTM)17.97x

Pretax Margin (TTM)-4632.91%

Book Value / Share (Annual)$0.96

Price vs S&P 500 (13W)-15.33%

Beta2.21x

Revenue / Share (TTM)$0.03

ROE (TTM)-120.70%

52-Week Low$0.16

vGradeD

gGradeF

mGradeD

vgmGradeF

Industry Peers — Health Services(17)

Symbol	Value Score	Growth Score	Momentum Score	Price
MGRXMangoceuticals, Inc. Common Stock	D	F	D	$0.39
FMSFresenius Medical Care AG	A	D	D	$23.51
DVADaVita Inc.	B	C	C	$177.80
SHCSotera Health Company Common Stock	D	B	B	$19.51
PGNYProgyny, Inc. Common Stock	C	B	C	$25.82
AGLagilon health, inc.	B	B	B	$96.11
MCTACharming Medical Limited Class A Ordinary Shares	F	F	A	$29.36
VMDViemed Healthcare, Inc. Common Shares	B	C	C	$9.10
PARKPark Dental Partners, Inc. Common Stock	B	C	C	$20.46
CCELCryo-Cell International Inc.	C	D	B	$4.30
BRTXBioRestorative Therapies, Inc. Common Stock (NV)	D	D	D	$0.22
NIVFNewGenIvf Group Limited Class A ordinary shares	A	B	F	$0.55
NIVFWNewGenIvf Group Limited Warrants	—	—	D	$0.02
OAKUOak Woods Acquisition Corporation Class A Ordinary Shares	—	F	C	$0.00
OAKUROak Woods Acquisition Corporation Right	—	F	C	$0.00
OAKUUOak Woods Acquisition Corporation Unit	—	F	C	$0.00
OAKUWOak Woods Acquisition Corporation Warrant	—	—	F	$0.00
QIPTQuipt Home Medical Corp. Ordinary Shares	B	B	B	$0.00

About Mangoceuticals, Inc. Common Stock

Mangoceuticals Inc operates a men's health telemedicine platform that connects patients with licensed providers for remote consultations and prescription services. The company leverages an integrated pharmacy network to fulfill and distribute medications, including its proprietary erectile dysfunction products. This vertically integrated model combines telehealth services with direct-to-consumer pharmacy fulfillment.